Viewing Study NCT02477332

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-05-16 @ 1:12 AM
Study NCT ID: NCT02477332
Status: COMPLETED
Last Update Posted: 2021-01-05
First Post: 2015-06-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Spontaneous Urticaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None QGE031 View
None ligelizumab View
None omalizumab View
None chronic View
None spontaneous View
None urticaria View
None adults View
None CSU View